LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trialXue Feng, Lai Wei, Wei Ma et al.|Journal of Hepatology|2024Cited by 27
Efficacy and Safety of HSK31679 in Asian Patients With MASLD: A Randomized Controlled TrialFeng Xue, Lai Wei, Wei Ma et al.|Clinical Gastroenterology and Hepatology|2025Cited by 2
Transcriptome sequencing and lncRNA-miRNA-mRNA network construction in cardiac fibrosis and heart failureShuo Wang, Yuying Liu, Enmao Wang et al.|Figshare|2022Cited by 0